{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:19:07Z","timestamp":1793323147642,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015565","name":"Consorzio Interuniversitario Biotecnologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bbcan.2024.189120","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T22:27:01Z","timestamp":1716676021000},"page":"189120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Carbonic anhydrase IX: An atypical target for innovative therapies in cancer"],"prefix":"10.1016","volume":"1879","author":[{"given":"Roberto","family":"Ronca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2024.189120_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143297","article-title":"Cancer therapeutic targeting of hypoxia induced carbonic anhydrase IX: from bench to bedside","volume":"14","author":"McDonald","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2024.189120_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2024.189120_bb0015","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbcan.2024.189120_bb0020","first-page":"1","article-title":"Targeting carbonic anhydrases for the management of hypoxic metastatic tumors","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bbcan.2024.189120_bb0025","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/13543784.2021.2014813","article-title":"Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors","volume":"30","author":"Supuran","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbcan.2024.189120_bb0030","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/anie.201310709","article-title":"A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors","volume":"53","author":"Krall","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bbcan.2024.189120_bb0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fphar.2017.00411","article-title":"Annual meeting of the International Society of Cancer Metabolism (ISCaM): metabolic networks in Cancer","volume":"8","author":"Baldini","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10100412","article-title":"Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment","volume":"10","author":"Angeli","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.bbcan.2024.189120_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1999194","article-title":"Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX","volume":"13","author":"Lenferink","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.bbcan.2024.189120_bb0050","first-page":"162","article-title":"Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?","volume":"1795","author":"Kaluz","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2024.189120_bb0055","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/molecules20022323","article-title":"Targeting carbonic anhydrase IX activity and expression","volume":"20","author":"Mahon","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bbcan.2024.189120_bb0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fcell.2018.00169","article-title":"Possible role of PHD inhibitors as hypoxia-mimicking agents in the maintenance of neural stem cells\u2019 self-renewal properties","volume":"6","author":"Wu","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2024.189120_bb0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189120_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbaexp.2005.03.003","article-title":"MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX","volume":"1729","author":"Kopacek","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2024.189120_bb0080","first-page":"4469","article-title":"Lowered oxygen tension induces expression of the hypoxia marker MN\/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3\u2032-kinase","volume":"62","author":"Kaluz","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0085","first-page":"1025","article-title":"Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia","volume":"29","author":"Ihnatko","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0090","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1128\/MCB.24.13.5757-5766.2004","article-title":"DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX","volume":"24","author":"Kaluzov\u00e1","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0095","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1074\/jbc.273.20.11995","article-title":"p53 inhibits hypoxia-inducible factor-stimulated transcription","volume":"273","author":"Blagosklonny","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0100","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2024.189120_bb0105","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2024.189120_bb0115","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M800938200","article-title":"Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes","volume":"283","author":"Hilvo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129411","article-title":"A simple yet multifaceted 90 years old, evergreen enzyme: carbonic anhydrase, its inhibition and activation","volume":"93","author":"Supuran","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2024.189120_bb0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2024.189120_bb0130","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors","volume":"48","author":"Cecchi","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0135","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00018-020-03697-3","article-title":"Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain","volume":"78","author":"Langella","year":"2021","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.bbcan.2024.189120_bb0140","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1016\/j.bmcl.2010.08.110","article-title":"Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of alpha- but not of beta-, gamma- and zeta-carbonic anhydrases","volume":"20","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2024.189120_bb0145","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3109\/14756366.2014.1001754","article-title":"Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity","volume":"30","author":"Uda","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0150","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jclinpath-2020-207073","article-title":"Carbonic anhydrase IX: a regulator of pH and participant in carcinogenesis","volume":"74","author":"Aldera","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0155","article-title":"Regulation and role of carbonic anhydrase IX and use as a biomarker and therapeutic target in cancer","volume":"15","author":"Mahon","year":"2013","journal-title":"Curr. Top. Biochem. Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0160","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2024.189120_bb0165","article-title":"The mechanism of Warburg effect-induced chemoresistance in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0170","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189120_bb0180","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1158\/0008-5472.CAN-11-2520","article-title":"Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors","volume":"71","author":"Ditte","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj0364","article-title":"Genome-wide synthetic lethal screen unveils novel CAIX-NFS1\/xCT axis as a targetable vulnerability in hypoxic solid tumors","volume":"7","author":"Chafe","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2024.189120_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.602668","article-title":"Interplay of carbonic anhydrase IX with amino acid and acid\/base transporters in the hypoxic tumor microenvironment","volume":"8","author":"Venkateswaran","year":"2020","journal-title":"Front. Cell Develop. Biol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1478-811X-11-81","article-title":"The effects of CA IX catalysis products within tumor microenvironment","volume":"11","author":"Santi","year":"2013","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2024.189120_bb0200","doi-asserted-by":"crossref","first-page":"24856","DOI":"10.18632\/oncotarget.4498","article-title":"Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models","volume":"6","author":"Ward","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189120_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082983","article-title":"Pharmacological inhibition of CA-IX impairs tumor cell proliferation, migration and invasiveness","volume":"21","author":"Ciccone","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189120_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111571","article-title":"Inhibition of carbonic anhydrase IX suppresses breast cancer cell motility at the single-cell level","volume":"22","author":"Janoniene","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189120_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218405","article-title":"A novel inhibitor of carbonic anhydrases prevents hypoxia-induced TNBC cell plasticity","volume":"21","author":"Sarnella","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189120_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051174","article-title":"Carbonic anhydrase IX promotes human cervical cancer cell motility by regulating PFKFB4 expression","volume":"13","author":"Hsin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2024.189120_bb0225","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbamem.2007.07.012","article-title":"Adherens and tight junctions: structure, function and connections to the actin cytoskeleton","volume":"1778","author":"Hartsock","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2024.189120_bb0230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0014-4827(03)00351-3","article-title":"Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin","volume":"290","author":"Svastov\u00e1","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0235","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1242\/jcs.072207","article-title":"Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion","volume":"124","author":"Shin","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2024.189120_bb0240","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cellsig.2012.03.002","article-title":"Dickkopf-1 (DKK-1) interrupts FAK\/PI3K\/mTOR pathway by interaction of carbonic anhydrase IX (CA9) in tumorigenesis","volume":"24","author":"Kim","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2024.189120_bb0245","doi-asserted-by":"crossref","first-page":"83088","DOI":"10.18632\/oncotarget.20236","article-title":"Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189120_bb0250","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/onc.2017.219","article-title":"The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia\/MMP14-mediated invasion","volume":"36","author":"Swayampakula","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2024.189120_bb0255","doi-asserted-by":"crossref","first-page":"1227884","DOI":"10.3389\/fonc.2023.1227884","article-title":"Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise","volume":"13","author":"Abd","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0260","doi-asserted-by":"crossref","DOI":"10.1242\/dev.200679","article-title":"Hypoxia induces an early primitive streak signature, enhancing spontaneous elongation and lineage representation in gastruloids","volume":"149","author":"Lopez-Anguita","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2024.189120_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8010013","article-title":"Carbonic anhydrase IX (CAIX), cancer, and radiation responsiveness","volume":"8","author":"Ward","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bbcan.2024.189120_bb0270","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2024.189120_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111382","article-title":"Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cells","volume":"535","author":"Schmidt","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0280","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13277-010-0042-8","article-title":"Radiation-induced cell death mechanisms","volume":"31","author":"Eriksson","year":"2010","journal-title":"Tumour Biol.: J. Intern. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.bbcan.2024.189120_bb0285","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1259\/0007-1285-26-312-609","article-title":"The initiation and development of cellular damage by ionizing radiations; the thirty-second Silvanus Thompson memorial lecture","volume":"26","author":"Gray","year":"1953","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0290","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2004.04.008","article-title":"Tumor microenvironmental physiology and its implications for radiation oncology","volume":"14","author":"Vaupel","year":"2004","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0295","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.ejca.2005.09.011","article-title":"The role of carbonic anhydrase IX overexpression in kidney cancer","volume":"41","author":"Dorai","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189120_bb0300","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1158\/0008-5472.CAN-07-6390","article-title":"Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts","volume":"68","author":"Park","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0305","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.onc.1209164","article-title":"beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury","volume":"25","author":"Cordes","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2024.189120_bb0310","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cyto.2012.03.011","article-title":"Role of radiation-induced granulocyte colony-stimulating factor in recovery from whole body gamma-irradiation","volume":"58","author":"Singh","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.bbcan.2024.189120_bb0315","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/0008-5472.CAN-14-3331","article-title":"STAT3 blockade inhibits radiation-induced malignant progression in glioma","volume":"75","author":"Lau","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0320","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10585-012-9475-3","article-title":"Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer","volume":"29","author":"Schoppmann","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbcan.2024.189120_bb0325","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.2016.327","article-title":"IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma","volume":"115","author":"Matsuoka","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189120_bb0330","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/0008-5472.CAN-14-3000","article-title":"Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production","volume":"75","author":"Chafe","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0335","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3892\/or.2015.4184","article-title":"Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation","volume":"34","author":"Duivenvoorden","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2024.189120_bb0340","article-title":"Modulation of tumor microenvironment to enhance radiotherapy efficacy in esophageal squamous cell carcinoma by inhibiting carbonic anhydrase IX","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0345","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bjc.6604844","article-title":"The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy","volume":"100","author":"Tan","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189120_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8010002","article-title":"Rethinking the combination of proton exchanger inhibitors in cancer therapy","volume":"8","author":"Iessi","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.bbcan.2024.189120_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216338","article-title":"The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-fluorouracil, taxane-derived, and platinum-based drugs","volume":"571","author":"Andreucci","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2024.189120_bb0360","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbcan.2024.189120_bb0365","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2024.189120_bb0370","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0375","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbcan.2024.189120_bb0380","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbcan.2024.189120_bb0385","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0390","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0395","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/jm0108202","article-title":"A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties","volume":"45","author":"Scozzafava","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105920","article-title":"A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors","volume":"126","author":"Kumar","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0405","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0410","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1021\/acs.molpharmaceut.8b00139","article-title":"Development of a small molecule Tubulysin B conjugate for treatment of carbonic anhydrase IX receptor expressing cancers","volume":"15","author":"Marks","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbcan.2024.189120_bb0415","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/cb1003477","article-title":"Selection of carbonic anhydrase IX inhibitors from one million DNA-encoded compounds","volume":"6","author":"Buller","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0420","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejmech.2018.04.005","article-title":"Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents","volume":"151","author":"Yu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113300","article-title":"Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR\/CAIX dual inhibitors","volume":"216","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112439","article-title":"Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases","volume":"200","author":"Elzahhar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0435","first-page":"1529","article-title":"Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250, journal of clinical oncology\u202f: official journal of the American society of","volume":"15","author":"Steffens","year":"1997","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11912-005-0036-7","article-title":"G250: a carbonic anhydrase IX monoclonal antibody","volume":"7","author":"Lam","year":"2005","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbcan.2024.189120_bb0445","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00345-010-0570-2","article-title":"A clinical phase I\/II trial with the monoclonal antibody cG250 (RENCAREX(R)) and interferon-alpha-2a in metastatic renal cell carcinoma patients","volume":"29","author":"Siebels","year":"2011","journal-title":"World. J. Urol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0450","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.3390\/ijms140611402","article-title":"Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma","volume":"14","author":"Oosterwijk-Wakka","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189120_bb0455","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.3892\/ijo.2014.2658","article-title":"Monoclonal antibody G250 targeting CA IX: binding specificity, internalization and therapeutic effects in a non-renal cancer model","volume":"45","author":"Zatovicova","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0460","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neo.2014.12.011","article-title":"Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC","volume":"17","author":"Oosterwijk-Wakka","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2024.189120_bb0465","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.eururo.2015.11.033","article-title":"Phase 2 study of lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody Girentuximab in patients with advanced renal cell carcinoma","volume":"69","author":"Muselaers","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0470","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamaoncol.2016.4419","article-title":"Adjuvant weekly Girentuximab following nephrectomy for high-risk renal cell carcinoma: the ARISER randomized clinical trial","volume":"3","author":"Chamie","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0475","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1158\/1078-0432.CCR-22-0921","article-title":"[89Zr]Zr-DFO-girentuximab and [18F]FDG PET\/CT to predict watchful waiting duration in patients with metastatic clear-cell renal cell carcinoma","volume":"29","author":"Verhoeff","year":"2023","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0480","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1054\/bjoc.2000.1111","article-title":"Human tumour-associated cell adhesion protein MN\/CA IX: identification of M75 epitope and of the region mediating cell adhesion","volume":"82","author":"Zavada","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189120_bb0485","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11142","article-title":"Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma","volume":"105","author":"Chrastina","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189120_bb0490","first-page":"13","article-title":"Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody","volume":"50","author":"Chrastina","year":"2003","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbcan.2024.189120_bb0495","article-title":"Molecular targeting of bioconjugated graphene oxide nanocarriers revealed at a cellular level using label-free Raman imaging","volume":"30","author":"Bugarova","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbcan.2024.189120_bb0500","doi-asserted-by":"crossref","first-page":"44497","DOI":"10.1021\/acsomega.3c01934","article-title":"Selective tumor hypoxia targeting using M75 antibody conjugated photothermally active MoO(x) nanoparticles","volume":"vol. 8","author":"Annusova","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbcan.2024.189120_bb0505","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/14756366.2021.2004593","article-title":"First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors","volume":"37","author":"Testa","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0510","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/1535-7163.MCT-11-0523","article-title":"Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9","volume":"11","author":"Petrul","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2024.189120_bb0515","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3389\/fonc.2019.01228","article-title":"A novel fully-human potency-matched dual cytokine-antibody fusion protein targets carbonic anhydrase IX in renal cell carcinomas","volume":"9","author":"De Luca","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0520","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2024.189120_bb0525","first-page":"359","article-title":"Long-term outcomes following CAR T cell therapy: what we know so far, nature reviews","volume":"20","author":"Cappell","year":"2023","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0530","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4049\/jimmunol.157.2.836","article-title":"Single chain Ig\/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity","volume":"157","author":"Weijtens","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0535","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1200\/JCO.2006.05.9964","article-title":"Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience","volume":"24","author":"Lamers","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0540","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1042\/BST20160037","article-title":"Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview","volume":"44","author":"Lamers","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbcan.2024.189120_bb0545","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/mt.2013.17","article-title":"Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity","volume":"21","author":"Lamers","year":"2013","journal-title":"Mol. Therapy: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.bbcan.2024.189120_bb0550","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2014.3","article-title":"Regression of established renal cell carcinoma in nude mice using lentivirus-transduced human T cells expressing a human anti-CAIX chimeric antigen receptor","volume":"1","author":"Lo","year":"2014","journal-title":"Mol. Therapy Oncolyt."},{"key":"10.1016\/j.bbcan.2024.189120_bb0555","doi-asserted-by":"crossref","first-page":"34341","DOI":"10.18632\/oncotarget.9114","article-title":"Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model","volume":"7","author":"Suarez","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189120_bb0560","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/CJI.0000000000000301","article-title":"CAIX-specific CAR-T cells and Sunitinib show synergistic effects against metastatic renal Cancer models","volume":"43","author":"Li","year":"2020","journal-title":"J. Immunother."},{"key":"10.1016\/j.bbcan.2024.189120_bb0565","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.omto.2021.12.019","article-title":"Anti-CAIX BBzeta CAR4\/8 T cells exhibit superior efficacy in a ccRCC mouse model","volume":"24","author":"Wang","year":"2022","journal-title":"Mol. Therapy Oncoly."},{"key":"10.1016\/j.bbcan.2024.189120_bb0570","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/neuonc\/noz117","article-title":"Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma","volume":"21","author":"Cui","year":"2019","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.bbcan.2024.189120_bb0575","first-page":"3714","article-title":"Bortezomib improves adoptive carbonic anhydrase IX-specific chimeric antigen receptor-modified NK92 cell therapy in mouse models of human renal cell carcinoma","volume":"40","author":"Zhang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2024.189120_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106399","article-title":"PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors","volume":"133","author":"Nerella","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113046","article-title":"Radiotracers for positron emission tomography (PET) targeting tumour-associated carbonic anhydrase isoforms","volume":"213","author":"Burianova","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0590","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/14756366.2022.2052868","article-title":"Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies","volume":"37","author":"Kciuk","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0595","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbcan.2024.189120_bb0600","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors","volume":"12","author":"Supuran","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413405","article-title":"Carbonic anhydrase IX inhibitors as candidates for combination therapy of solid tumors","volume":"22","author":"Kalinin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189120_bb0610","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/14756366.2012.736979","article-title":"Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro","volume":"28","author":"Gieling","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0615","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.taap.2016.12.017","article-title":"Shouman, carbonic anhydrase inhibition boosts the antitumor effects of Imatinib mesylate via potentiating the antiangiogenic and antimetastatic machineries","volume":"316","author":"Abd-El Fattah","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbcan.2024.189120_bb0620","first-page":"9299","article-title":"Combined treatment with acetazolamide and cisplatin enhances chemosensitivity in laryngeal carcinoma Hep-2 cells","volume":"15","author":"Gao","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2024.189120_bb0625","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12885-017-3126-7","article-title":"Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma","volume":"17","author":"Bayat Mokhtari","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2024.189120_bb0630","doi-asserted-by":"crossref","first-page":"36666","DOI":"10.18632\/oncotarget.9134","article-title":"Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors","volume":"7","author":"Faes","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189120_bb0635","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1007\/s13277-016-4785-8","article-title":"Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma","volume":"37","author":"Vaeteewoottacharn","year":"2016","journal-title":"Tumour Biol.: J. Intern. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.bbcan.2024.189120_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145001","article-title":"Carbonic anhydrase inhibitor acetazolamide enhances CHOP treatment response and stimulates effector T-cell infiltration in A20\/BalbC murine B-cell lymphoma","volume":"21","author":"Mehes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189120_bb0645","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14756366.2018.1532419","article-title":"The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy","volume":"34","author":"Andreucci","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbcan.2024.189120_bb0650","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2024.189120_bb0655","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","article-title":"Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic Cancer cells with activated KRAS in response to hypoxia","volume":"157","author":"McDonald","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2024.189120_bb0660","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1158\/1535-7163.MCT-16-0253","article-title":"Regulation of HIF1alpha under hypoxia by APE1\/Ref-1 impacts CA9 expression: dual targeting in patient-derived 3D pancreatic cancer models","volume":"15","author":"Logsdon","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2024.189120_bb0665","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.1038\/s41598-018-32034-9","article-title":"Blocking HIF signaling via novel inhibitors of CA9 and APE1\/Ref-1 dramatically affects pancreatic cancer cell survival","volume":"8","author":"Logsdon","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2024.189120_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11071002","article-title":"Harnessing induced essentiality: targeting carbonic anhydrase IX and angiogenesis reduces lung metastasis of triple negative breast cancer xenografts","volume":"11","author":"Hedlund","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2024.189120_bb0675","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-022-02345-x","article-title":"Inhibition of carbonic anhydrases IX\/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion","volume":"41","author":"Sarnella","year":"2022","journal-title":"J. Exper. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.bbcan.2024.189120_bb0680","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","article-title":"Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically","volume":"7","author":"Chafe","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2024.189120_bb0685","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jconrel.2021.10.011","article-title":"A nanoplatform to boost multi-phases of cancer-immunity-cycle for enhancing immunotherapy","volume":"339","author":"Zheng","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbcan.2024.189120_bb0690","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1111\/jcmm.17027","article-title":"Pharmacological inhibition of carbonic anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell. Mol. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T01:32:16Z","timestamp":1718242336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":138,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0304419X24000519"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189120","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonic anhydrase IX: An atypical target for innovative therapies in cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189120"}}